A detailed history of Israel Englander (Millennium Management LLC) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Millennium Management LLC holds 2,408,197 shares of SGMO stock, worth $5.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,408,197
Previous 1,104,877 117.96%
Holding current value
$5.95 Million
Previous $740,000 17.03%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.65 $469,195 - $847,158
1,303,320 Added 117.96%
2,408,197 $866,000
Q1 2024

May 15, 2024

SELL
$0.42 - $1.38 $7,443 - $24,456
-17,722 Reduced 1.58%
1,104,877 $740,000
Q4 2023

Feb 14, 2024

BUY
$0.3 - $0.63 $61,543 - $129,241
205,145 Added 22.36%
1,122,599 $606,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $1.74 $676,124 - $1.06 Million
609,121 Added 197.55%
917,454 $1.19 Million
Q1 2023

May 15, 2023

BUY
$1.66 - $3.67 $159,897 - $353,509
96,324 Added 45.43%
308,333 $543,000
Q4 2022

Feb 14, 2023

SELL
$2.77 - $5.07 $1.14 Million - $2.09 Million
-413,188 Reduced 66.09%
212,009 $666,000
Q3 2022

Nov 14, 2022

SELL
$4.27 - $6.39 $2.48 Million - $3.71 Million
-581,055 Reduced 48.17%
625,197 $3.06 Million
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.21 $1.69 Million - $3.2 Million
515,625 Added 74.66%
1,206,252 $4.99 Million
Q1 2022

May 16, 2022

SELL
$5.23 - $7.82 $3.21 Million - $4.8 Million
-613,227 Reduced 47.03%
690,627 $4.01 Million
Q4 2021

Feb 14, 2022

BUY
$7.29 - $10.97 $8.05 Million - $12.1 Million
1,104,235 Added 553.17%
1,303,854 $9.78 Million
Q3 2021

Nov 15, 2021

BUY
$9.01 - $12.01 $376,329 - $501,633
41,768 Added 26.46%
199,619 $1.8 Million
Q2 2021

Aug 16, 2021

BUY
$10.17 - $12.64 $425,899 - $529,337
41,878 Added 36.11%
157,851 $1.89 Million
Q1 2021

May 17, 2021

SELL
$10.88 - $17.05 $576,574 - $903,547
-52,994 Reduced 31.36%
115,973 $1.45 Million
Q4 2020

Feb 16, 2021

SELL
$9.23 - $18.18 $3.52 Million - $6.94 Million
-381,765 Reduced 69.32%
168,967 $2.64 Million
Q3 2020

Nov 16, 2020

BUY
$9.38 - $12.48 $5.17 Million - $6.87 Million
550,732 New
550,732 $5.2 Million
Q2 2020

Aug 14, 2020

SELL
$6.21 - $11.83 $9.24 Million - $17.6 Million
-1,488,020 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$5.05 - $8.85 $7.51 Million - $13.2 Million
1,488,020 New
1,488,020 $9.48 Million
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $95,217 - $141,792
-10,882 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$7.72 - $12.81 $84,009 - $139,398
10,882 New
10,882 $104,000
Q4 2018

Feb 14, 2019

SELL
$9.51 - $16.6 $4.42 Million - $7.72 Million
-464,840 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$13.05 - $19.05 $5.85 Million - $8.53 Million
447,932 Added 2649.23%
464,840 $7.88 Million
Q2 2018

Aug 14, 2018

SELL
$13.9 - $19.8 $1.08 Million - $1.54 Million
-77,756 Reduced 82.14%
16,908 $240,000
Q1 2018

May 15, 2018

SELL
$16.7 - $26.35 $3.04 Million - $4.8 Million
-182,127 Reduced 65.8%
94,664 $1.8 Million
Q4 2017

Feb 14, 2018

SELL
$11.6 - $17.35 $7.72 Million - $11.5 Million
-665,306 Reduced 70.62%
276,791 $4.54 Million
Q3 2017

Nov 14, 2017

BUY
$8.4 - $15.0 $7.91 Million - $14.1 Million
942,097
942,097 $14.1 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $387M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.